Molecular Biology

B. Mosley, M.P. Beckmann, C.J. March, R.L. Idzerda, S.D. Gimpel, T. VandenBos, D. Friend, A. Alpert, D. Anderson, J. Jackson, J.M. Wignall, C. Smith, B. Gallis, J.E. Sims, D. Urdal, M.B. Widmer, D. Cosman, L.S. Park, "The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms," Cell, 59, 335-48, 20 October 1989. David Cosman (Immunex Corp., Seattle): "I can think of several reasons why our paper has been cited. There is substantial interest i

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

B. Mosley, M.P. Beckmann, C.J. March, R.L. Idzerda, S.D. Gimpel, T. VandenBos, D. Friend, A. Alpert, D. Anderson, J. Jackson, J.M. Wignall, C. Smith, B. Gallis, J.E. Sims, D. Urdal, M.B. Widmer, D. Cosman, L.S. Park, "The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms," Cell, 59, 335-48, 20 October 1989.

David Cosman (Immunex Corp., Seattle): "I can think of several reasons why our paper has been cited. There is substantial interest in the pleiotropic biological activities of interleukin 4 (IL-4), and the molecular cloning of the IL-4 receptor provides a necessary first step toward understanding how IL-4 transduces so many different signals in different cell types. The structure of the extracellular, ligand-binding domain of the receptor showed significant homology with other cytokine receptors (IL-2Rb, erythropoietin, IL-6), and we and others have since extended this observation to define an extensive new family of cytokine receptors. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies